Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 26, 2015
HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial
Kimberly Butterwick, Ellen Marmur, Vic Narurkar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal
|
April 4, 2024
A Multicenter, Randomized, Evaluator-Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows
Brian S Biesman, Jeremy B Green, Rosalyn George, et al.
Aesthetic Surgery Journal
|
June 15, 2022
Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
John H Joseph, Corey Maas, Melanie D Palm, et al.
Journal of Cosmetic Dermatology
|
October 8, 2022
Real-world effectiveness and safety of collagenase clostridium histolyticum-aaes injections for the treatment of thigh cellulite in women: An open-label study interim analysis
John H Joseph, Steven H Dayan, Ashish C Bhatia, et al.
Aesthetic Surgery Journal
|
September 4, 2012
Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review
Corey Maas, Michael A C Kane, Vivian W Bucay, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 1, 2022
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
Lawrence S Bass, Joely Kaufman-Janette, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
Joely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Aesthetic Surgery Journal
|
May 4, 2021
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Z Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Aesthetic Surgery Journal
|
June 30, 2021
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Z Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
November 26, 2015
HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial
Kimberly Butterwick, Ellen Marmur, Vic Narurkar, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 18, 2015
REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction
Derek H Jones, Jean Carruthers, John H Joseph, et al.
Aesthetic Surgery Journal
|
April 4, 2024
A Multicenter, Randomized, Evaluator-Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows
Brian S Biesman, Jeremy B Green, Rosalyn George, et al.
Aesthetic Surgery Journal
|
June 15, 2022
Safety, Pharmacodynamic Response, and Treatment Satisfaction With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With Moderate to Severe Dynamic Glabellar Lines
John H Joseph, Corey Maas, Melanie D Palm, et al.
Journal of Cosmetic Dermatology
|
October 8, 2022
Real-world effectiveness and safety of collagenase clostridium histolyticum-aaes injections for the treatment of thigh cellulite in women: An open-label study interim analysis
John H Joseph, Steven H Dayan, Ashish C Bhatia, et al.
Aesthetic Surgery Journal
|
September 4, 2012
Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review
Corey Maas, Michael A C Kane, Vivian W Bucay, et al.
Plastic and Reconstructive Surgery. Global Open
|
June 1, 2022
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
Lawrence S Bass, Joely Kaufman-Janette, John H Joseph, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 12, 2021
Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials
Joely Kaufman-Janette, John H Joseph, Michael S Kaminer, et al.
Aesthetic Surgery Journal
|
May 4, 2021
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Z Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Aesthetic Surgery Journal
|
June 30, 2021
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Z Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Page
of 4